Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alexion Shares Hit 52-Week High
TheStreet.com
Monday, January 9, 2012 - 11:41am
tags:
Alexion
JPM kicks off with fevered focus on the next big biotech deal
Fierce Biotech
Monday, January 9, 2012 - 10:42am
tags:
JPMorgan, biotech, M&A, Inhibitex, Bristol-Myers Squibb
Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Monday, January 9, 2012 - 10:40am
tags:
drug launches, Dendreon, Incyte, Human Genome Sciences, Regeneron, Seattle Genetics, Vertex
2 ETFs To Play A Surge In Biotech/Pharma M&A
Seeking Alpha
Monday, January 9, 2012 - 10:39am
tags:
Abbott Laboratories, Amgen, Biogen Idec, Gilead, Celgene, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, Pfizer, ETFs
Vivus obesity drug may get broader label
Reuters
Monday, January 9, 2012 - 10:30am
tags:
obesity, Vivus, Qnexa
Idenix reports positive interim data for HCV Nucleotide Inhibitor, IDX184
Yahoo/Fly on the Wall
Monday, January 9, 2012 - 10:30am
tags:
Idenix, hepatitis C, nucleotide inhibitor, IDX184
Dendreon Rally Justified, But Outstanding Issues May Limit Upside
Seeking Alpha
Monday, January 9, 2012 - 10:29am
tags:
Dendreon, Provenge
There have been red faces at AstraZeneca after the company sent confidential information to analysts by mistake
InPharm
Monday, January 9, 2012 - 10:14am
tags:
guidance, AstraZeneca
Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Bloomberg
Monday, January 9, 2012 - 10:12am
tags:
Bristol-Myers Squibb, M&A, Inhibitex, hepatitis C
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
Xconomy
Monday, January 9, 2012 - 10:10am
tags:
JPMorgan, IPOs, Amgen, FDA, innovation
Novartis Recalls OTC Meds Made At Troubled Plant
Pharmalot
Monday, January 9, 2012 - 10:03am
tags:
Novartis, recalls, OTC
Optimer provides update on DIFICID tablets launch
The Fly on the Wall
Monday, January 9, 2012 - 10:01am
tags:
Optimer, Dificid
Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Monday, January 9, 2012 - 9:57am
tags:
hepatitis C, Bristol-Myers Squibb, M&A, Inhibitex, Gilead, Pharmasset
BDSI Might Again Be Ready For Prime Time
Seeking Alpha
Monday, January 9, 2012 - 9:55am
tags:
BioDelivery Sciences, BEMA Buprenorphine, Endo
S&P: Bristol-Myers announcement will not affect rating
Reuters
Monday, January 9, 2012 - 9:53am
tags:
Bristol-Myers Squibb, M&A, Inhibitex
UK cost agency wants more data on Bayer anti-clot drug
Reuters
Monday, January 9, 2012 - 9:52am
tags:
UK, Bayer, Xarelto
AstraZeneca reaffirms EPS guidance for 2011
Marketwatch
Monday, January 9, 2012 - 9:51am
tags:
AstraZeneca, guidance
Theravance Shares Slide on Lung Drug Deaths
TheStreet.com
Monday, January 9, 2012 - 9:51am
tags:
Relovair, GSK, Theravance
J&J to Oppose Texas in $1 Billion Trial Over Risperdal Marketing Practices
Bloomberg
Monday, January 9, 2012 - 9:23am
tags:
off-label, JNJ, Texas, Risperdal
Biotech drug makers aim to extend brand dominance
Reuters
Monday, January 9, 2012 - 9:18am
tags:
branding, biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.